What is the ticker symbol for BioCardia?

BioCardia trades under the ticker BCDAW on NASDAQ.

What sector does BioCardia operate in?

BioCardia is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BCDAW in a portfolio?

PortView shows BCDAW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

BioCardia (BCDAW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.01-3.17%

1-year price historyRange $0.01 – $1.42

52-week range$0.01

$0.01$0.01

What BioCardia does

BioCardia, Inc. is a regenerative medicine enterprise, currently in the clinical development phase, dedicated to devising cell-based and cell-derived treatments for cardiac and pulmonary ailments. Its primary therapeutic offering is CardiAMP, an autologous mononuclear cell therapy system designed to address heart failure and persistent myocardial ischemia. In parallel, the company is advancing allogeneic cell therapies for various heart and lung diseases, including an investigational platform utilizing culture-expanded bone marrow-derived mesenchymal cells, which is presently in Phase I/II trials for ischemic heart failure. Beyond its therapeutic pipeline, BioCardia provides the Helix biotherapeutic delivery system, engineered to precisely inject treatments into the heart muscle via an internal helical needle, alongside Morph deflectable guides and sheaths. The company's operations are headquartered in Sunnyvale, California.

Key metrics

Market cap

$10,116

P/E (TTM)

-0.00

EPS (TTM)

$-3.20

Beta

1.36

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.00

200-day avg

$0.00

52-week high

$0.01

52-week low

$0.01

CEO

Peter A. Altman

ETFs linked to BCDAW

Broad-market and Healthcare sector ETFs an investor holding BioCardia is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BCDAW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BCDAW in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for BioCardia?: BioCardia trades under the ticker BCDAW on NASDAQ.
Which exchange is BCDAW listed on?: BCDAW is listed on NASDAQ.
What sector does BioCardia operate in?: BioCardia is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BCDAW in a portfolio?: PortView shows BCDAW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.